PD-1/PD-L1 Inhibitors in Cervical Cancer

Cervical cancer is one of the most common gynecological tumors, and the majority of early-stage cervical cancer patients achieve good recovery through surgical treatment and concurrent chemoradiotherapy (CCRT). However, for patients with recurrent, persistent, metastatic cervical cancer, effective t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Liu, Yuncong, Wu, Li, Tong, Ruizhan, Yang, Feiyue, Yin, Limei, Li, Mengqian, You, Liting, Xue, Jianxin, Lu, You
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6367228/
https://ncbi.nlm.nih.gov/pubmed/30774597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00065
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados